Tolerogenic dendritic cells as a target for the therapy of immune thrombocytopenia

Clinical and Applied Thrombosis/Hemostasis

Volumn 18, Issue 5, 2012, Pages 469-475

  Fu, Jinqiu ^a,b   Zhang, Aijun ^b   Ju, Xiuli ^b  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

autoimmune; dendritic cells; immune thrombocytopenia; tolerogenic DCs; Tregs

Indexed keywords

ALPHA INTERFERON; B7 ANTIGEN; BETA CATENIN; CD40 ANTIGEN; CD40 LIGAND; CD86 ANTIGEN; FC RECEPTOR IIB; GAMMA INTERFERON; GLYCOPROTEIN P 15095; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE T CELL COSTIMULATOR LIGAND; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 25; INTERLEUKIN 3; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; P SELECTIN GLYCOPROTEIN LIGAND 1; PADGEM PROTEIN; PROGRAMMED DEATH 1 LIGAND 1; THROMBOCYTE ANTIBODY; UVOMORULIN;

ANTIGEN SPECIFICITY; AUTOIMMUNE THROMBOCYTOPENIA; AUTOIMMUNITY; B LYMPHOCYTE; CELL MATURATION; CELLULAR IMMUNITY; CYTOKINE RELEASE; DENDRITIC CELL; GENETIC ENGINEERING; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOTHERAPY; MACROPHAGE; MYELOID DENDRITIC CELL; NONHUMAN; PHAGOCYTOSIS; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; TH1 CELL; TH2 CELL; THROMBOCYTE; TOLEROGENIC DENDRITIC CELL;

AUTOANTIBODIES; B-LYMPHOCYTES; BLOOD PLATELETS; DENDRITIC CELLS; HUMANS; IMMUNE TOLERANCE; IMMUNITY, HUMORAL; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; VACCINATION;

EID: 84871816287     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029612438612     Document Type: Review

References (106)

1. Hsu NC, Chung CY, Horng HC, Chang CS. Corticosteroid administration depresses circulating dendritic cells in ITP patients. Platelets. 2004 ; 15 (7). 451-454
2. Bussel JB. The changing landscape of secondary ITP: introduction. Semin Hematol. 2009 ; 46 (1 suppl 2). S1
3. Gudbrandsdottir S, Frederiksen H, Birgens HS, et al. The pathogenesis of primary immune thrombocytopenia [in Danish]. Ugeskr Laeger. 2011 ; 173 (4). 274-277
4. Neunert C, Lim W, Crowther M, et al. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011 ; 117 (16). 4190-4207
5. Citak EC, Citak FE. Treatment results of children with chronic immune thrombocytopenic purpura (ITP) treated with rituximab. J Trop Pediatr. 2011 ; 57 (1). 71-72
6. Crow AR, Song S, Suppa SJ, et al. Amelioration of murine immune thrombocytopenia by CD44 antibodies: a potential therapy for ITP?. Blood. 2011 ; 117 (3). 971-974
7. Flores-Borja F, Mauri C, Ehrenstein MR. Restoring the balance: harnessing regulatory T cells for therapy in rheumatoid arthritis. Eur J Immunol. 2008 ; 38 (4). 934-937
8. Imperato AK, Bingham CO, Abramson SB. Overview of benefit/risk of biological agents. Clin Exp Rheumatol. 2004 ; 22 (5 suppl 35). S108 - S114
9. Rutella S, Danese S, Leone G. Tolerogenic dendritic cells: cytokine modulation comes of age. Blood. 2006 ; 108 (5). 1435-1440
10. Rescigno M. Dendritic cells in tolerance induction for the treatment of autoimmune diseases. Eur J Immunol. 2010 ; 40 (8). 2119-2123
11. Zanoni I, Granucci F. The regulatory role of dendritic cells in the induction and maintenance of T-cell tolerance. Autoimmunity. 2010 ; 44 (1). 23-32
12. Kuwana M. Induction of anergic and regulatory T cells by plasmacytoid dendritic cells and other dendritic cell subsets. Hum Immunol. 2002 ; 63 (12). 1156-1163
13. Ohnmacht C, Pullner A, King SB, et al. Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity. J Exp Med. 2009 ; 206 (3). 549-559
14. Crow AR, Song S, Siragam V, Lazarus AH. Mechanisms of action of intravenous immunoglobulin in the treatment of immune thrombocytopenia. Pediatr Blood Cancer. 2006 ; 47 (5 suppl). 710-713
15. Tuettenberg A, Huter E, Hubo M, et al. The role of ICOS in directing T cell responses: ICOS-dependent induction of T cell anergy by tolerogenic dendritic cells. J Immunol. 2009 ; 182 (6). 3349-3356
16. Bros M, Jährling F, Renzing A, et al. A newly established murine immature dendritic cell line can be differentiated into a mature state, but exerts tolerogenic function upon maturation in the presence of glucocorticoid. Blood. 2007 ; 109 (9). 3820-3829
17. Catani L, Sollazzo D, Ricci F, et al. The CD47 pathway is deregulated in human immune thrombocytopenia. Exp Hematol. 2011 ; 39 (4). 486-494
18. Huang H, Dawicki W, Zhang X, Town J, Gordon JR. Tolerogenic dendritic cells induce CD4+CD25hiFoxp3+ regulatory T cell differentiation from CD4+CD25-/loFoxp3- effector T cells. J Immunol. 2010 ; 185 (9). 5003-5010
19. Thomson AW, Turnquist HR, Zahorchak AF, Raimondi G. Tolerogenic dendritic cell-regulatory T-cell interaction and the promotion of transplant tolerance. Transplantation. 2009 ; 87 (9 suppl). S86 - S90
20. Dzionek A, Fuchs A, Schmidt P, et al. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol. 2000 ; 165 (11). 6037-6046
21. Palucka AK, Banchereau J, Blanco P, Pascual V. The interplay of dendritic cell subsets in systemic lupus erythematosus. Immunol Cell Biol. 2002 ; 80 (5). 484-488
22. Jongbloed SL, Lebre MC, Fraser AR, et al. Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis. Arthritis Res Ther. 2006 ; 8 (1). R15
23. van Lieshout AW, Barrera P, Smeets RL, et al. Inhibition of TNF alpha during maturation of dendritic cells results in the development of semi-mature cells: a potential mechanism for the beneficial effects of TNF alpha blockade in rheumatoid arthritis. Ann Rheum Dis. 2005 ; 64 (3). 408-414
24. Santiago-Schwarz F, Anand P, Liu S, Carsons SE. Dendritic cells (DCs) in rheumatoid arthritis (RA): progenitor cells and soluble factors contained in RA synovial fluid yield a subset of myeloid DCs that preferentially activate Th1 inflammatory-type responses. J Immunol. 2001 ; 167 (3). 1758-1768
25. Leon B, Ardavin C. Monocyte-derived dendritic cells in innate and adaptive immunity. Immunol Cell Biol. 2008 ; 86 (4). 320-324
26. Auffray C, Sieweke MH, Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol. 2009 ; 27: 669-692
27. Geissmann F, Manz MG, Jung S, et al. Development of monocytes, macrophages, and dendritic cells. Science. 2010 ; 327 (5966). 656-661
28. Liu K, Nussenzweig MC. Origin and development of dendritic cells. Immunol Rev. 2010 ; 234 (1). 45-54
29. Ling Y, Cao X, Yu Z, Ruan C. Circulating dendritic cells subsets and CD4+Foxp3+ regulatory T cells in adult patients with chronic ITP before and after treatment with high-dose dexamethasome. Eur J Haematol. 2007 ; 79 (4). 310-316
30. Steinman RM, Witmer MD. Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice. Proc Natl Acad Sci U S A. 1978 ; 75 (10). 5132-5136
31. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998 ; 392 (6673). 245-252
32. Winzler C, Rovere P, Rescigno M, et al. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J Exp Med. 1997 ; 185 (2). 317-328
33. Sallusto F, Schaerli P, Loetscher P, et al. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur J Immunol. 1998 ; 28 (9). 2760-2769
34. Schulz O, Edwards AD, Schito M, et al. CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal. Immunity. 2000 ; 13 (4). 453-462
35. Qi H, Li FR, Liu DZ, et al. Study on the surface markers on peripheral blood dendritic cells and their secretion of IL-12 and IFN-alpha in SLE patients [in Chinese]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2005 ; 21 (4). 499-501
36. Park H, Li Z, Yang XO, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 2005 ; 6 (11). 1133-1141
37. Klein L, Hinterberger M, Wirnsberger G, Kyewski B. Antigen presentation in the thymus for positive selection and central tolerance induction. Nat Rev Immunol. 2009 ; 9 (12). 833-844
38. Bonasio R, Scimone ML, Schaerli P, Grabie N, Lichtman AH, von Andrian UH. Clonal deletion of thymocytes by circulating dendritic cells homing to the thymus. Nat Immunol. 2006 ; 7 (10). 1092-1100
39. Volkmann A, Zal T, Stockinger B. Antigen-presenting cells in the thymus that can negatively select MHC class II-restricted T cells recognizing a circulating self antigen. J Immunol. 1997 ; 158 (2). 693-706
40. Proietto AI, van Dommelen S, Zhou P, et al. Dendritic cells in the thymus contribute to T-regulatory cell induction. Proc Natl Acad Sci U S A. 2008 ; 105 (50). 19869-19874
41. Watanabe N, Wang YH, Lee HK, et al. Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature. 2005 ; 436 (7054). 1181-1185
42. Martin-Gayo E, Sierra-Filardi E, Corbi AL, Toribio ML. Plasmacytoid dendritic cells resident in human thymus drive natural Treg cell development. Blood. 2010 ; 115 (26). 5366-5375
43. Hanabuchi S, Ito T, Park WR, et al. Thymic stromal lymphopoietin- activated plasmacytoid dendritic cells induce the generation of FOXP3+ regulatory T cells in human thymus. J Immunol. 2010 ; 184 (6). 2999-3007
44. Desai DD, Harbers SO, Flores M, et al. Fc gamma receptor IIB on dendritic cells enforces peripheral tolerance by inhibiting effector T cell responses. J Immunol. 2007 ; 178 (10). 6217-6226
45. Gad M, Claesson MH, Pedersen AE. Dendritic cells in peripheral tolerance and immunity. APMIS. 2003 ; 111 (7-8). 766-775
46. Probst HC, McCoy K, Okazaki T, Honjo T, van den Broek M. Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4. Nat Immunol. 2005 ; 6 (3). 280-286
47. Hadeiba H, Sato T, Habtezion A, Oderup C, Pan J, Butcher EC. CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease. Nat Immunol. 2008 ; 9 (11). 1253-1260
48. Bergtold A, Desai DD, Gavhane A, Clynes R. Cell surface recycling of internalized antigen permits dendritic cell priming of B cells. Immunity. 2005 ; 23 (5). 503-514
49. Fayolle C, Davi M, Dong H, et al. Induction of anti-Tat neutralizing antibodies by the CyaA vector targeting dendritic cells: influence of the insertion site and of the delivery of multicopies of the dominant Tat B-cell epitope. Vaccine. 2010 ; 28 (42). 6930-6941
50. Wai LE, Garcia JA, Martinez OM, Krams SM. Distinct roles for the NK cell-activating receptors in mediating interactions with dendritic cells and tumor cells. J Immunol. 2011 ; 186 (1). 222-229
51. Persson CM, Chambers BJ. Plasmacytoid dendritic cell-induced migration and activation of NK cells in vivo. Eur J Immunol. 2010 ; 40 (8). 2155-2164
52. Bar-On L, Jung S. Defining dendritic cells by conditional and constitutive cell ablation. Immunol Rev. 2010 ; 234 (1). 76-89
53. Thomson AW, Robbins PD.. Tolerogenic dendritic cells for autoimmune disease and transplantation. Ann Rheum Dis. 2008 ; 67 (suppl 3). iii90 - iii96
54. Hackstein H, Thomson AW. Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat Rev Immunol. 2004 ; 4 (1). 24-34
55. Adorini L, Giarratana N, Penna G. Pharmacological induction of tolerogenic dendritic cells and regulatory T cells. Semin Immunol. 2004 ; 16 (2). 127-134
56. Lagaraine C, Lebranchu Y.. Effects of immunosuppressive drugs on dendritic cells and tolerance induction. Transplantation. 2003 ; 75 (9 suppl). 37S - 42S
57. Saito M, Nagasawa M, Takada H, et al. Defective IL-10 signaling in hyper-IgE syndrome results in impaired generation of tolerogenic dendritic cells and induced regulatory T cells. J Exp Med. 2011 ; 208 (2). 235-249
58. Zanetti M, Castiglioni P, Schoenberger S, Gerloni M. The role of relB in regulating the adaptive immune response. Ann N Y Acad Sci. 2003 ; 987: 249-257
59. Popov I, Li M, Zheng X, et al. Preventing autoimmune arthritis using antigen-specific immature dendritic cells: a novel tolerogenic vaccine. Arthritis Res Ther. 2006 ; 8 (5). R141
60. Kabalak G, Dobberstein SB, Matthias T, et al. Association of immunoglobulin-like transcript 6 deficiency with Sjogren's syndrome. Arthritis Rheum. 2009 ; 60 (10). 2923-2925
61. Chen W, Liang X, Peterson AJ, Munn DH, Blazar BR. The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation. J Immunol. 2008 ; 181 (8). 5396-5404
62. Manches O, Munn D, Fallahi A, et al. HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism. J Clin Invest. 2008 ; 118 (10). 3431-3439
63. Urzainqui A, Martínez del Hoyo G, Lamana A, et al. Functional role of P-selectin glycoprotein ligand 1/P-selectin interaction in the generation of tolerogenic dendritic cells. J Immunol. 2007 ; 179 (11). 7457-7465
64. Fu C, Jiang A. Generation of tolerogenic dendritic cells via the E-cadherin/beta-catenin-signaling pathway. Immunol Res. 2010 ; 46 (1-3). 72-78
65. Perone MJ, Larregina AT, Shufesky WJ, et al. Transgenic galectin-1 induces maturation of dendritic cells that elicit contrasting responses in naive and activated T cells. J Immunol. 2006 ; 176 (12). 7207-7220
66. Li YH, Chu NS, Rostami A, Zhang GX. Dendritic cells transduced with SOCS-3 exhibit a tolerogenic/DC2 phenotype that directs type 2 Th cell differentiation in vitro and in vivo. J Immunol. 2006 ; 177 (3). 1679-1688
67. Zheng XF, Suzuki M, Ichim TE, et al. Treatment of autoimmune arthritis using RNA interference-modulated dendritic cells. J Immunol. 2010 ; 184 (11). 6457-6464
68. Bianco NR, Kim SH, Ruffner MA, Robbins PD. Therapeutic effect of exosomes from indoleamine 2,3-dioxygenase-positive dendritic cells in collagen-induced arthritis and delayed-type hypersensitivity disease models. Arthritis Rheum. 2009 ; 60 (2). 380-389
69. Zheng XF, Suzuki M, Zhang X, et al. RNAi-mediated CD40-CD154 interruption promotes tolerance in autoimmune arthritis. Arthritis Res Ther. 2010 ; 12 (1). R13
70. Beardsley DS. ITP in the 21st century. Hematology Am Soc Hematol Educ Program. 2006 ;: 402-407
71. Zhou Z, Li X, Li J, et al. Direct B-cell stimulation by peripheral blood monocyte-derived dendritic cells in idiopathic thrombocytopenic purpura patients. J Clin Immunol. 2010 ; 30 (6). 814-822
72. Papenfuss TL, Powell ND, McClain MA, et al. Estriol generates tolerogenic dendritic cells In Vivo that protect against autoimmunity. J Immunol. 2011 ; 186 (6). 3346-3355
73. Torres-Aguilar H, Blank M, Jara LJ, Shoenfeld Y. Tolerogenic dendritic cells in autoimmune diseases: crucial players in induction and prevention of autoimmunity. Autoimmun Rev. 2010 ; 10 (1). 8-17
74. Hu J, Wan Y. Tolerogenic dendritic cells and their potential applications. Immunology. 2011 ; 132 (3). 307-314
75. Crow AR, Lazarus AH. Role of Fcgamma receptors in the pathogenesis and treatment of idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol. 2003 ; 25 (suppl 1). S14 - S18
76. Liu XG, Ma SH, Sun JZ, et al. High-dose dexamethasone shifts the balance of stimulatory and inhibitory Fcgamma receptors on monocytes in patients with primary immune thrombocytopenia. Blood. 2011 ; 117 (6). 2061-2069
77. Foster CB, Zhu S, Erichsen HC, et al. Polymorphisms in inflammatory cytokines and Fcgamma receptors in childhood chronic immune thrombocytopenic purpura: a pilot study. Br J Haematol. 2001 ; 113 (3). 596-599
78. Siragam V, et al. Intravenous immunoglobulin ameliorates ITP via activating Fc gamma receptors on dendritic cells. Nat Med. 2006 ; 12 (6). 688-692
79. Huang HS, Sun DS, Lien TS, Chang HH. Dendritic cells modulate platelet activity in IVIg-mediated amelioration of ITP in mice. Blood. 2010 ; 116 (23). 5002-5009
80. Zhu X, Ma D, Zhang J, et al. Elevated interleukin-21 correlated to Th17 and Th1 cells in patients with immune thrombocytopenia. J Clin Immunol. 2010 ; 30 (2). 253-259
81. Zhang J, Ma D, Zhu X, Qu X, Ji C, Hou M.. Elevated profile of Th17, Th1 and Tc1 cells in patients with immune thrombocytopenic purpura. Haematologica. 2009 ; 94 (9). 1326-1329
82. Panitsas FP, Theodoropoulou M, Kouraklis A, et al. Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response. Blood. 2004 ; 103 (7). 2645-2647
83. Olsson B, Andersson PO, Jernås M, et al. T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nat Med. 2003 ; 9 (9). 1123-1124
84. Wojas J, Pajtasz-Piasecka E. Dendritic cell-regulatory T-cell interaction [in polish]. Postepy Hig Med Dosw (Online). 2010 ; 64: 167-174
85. Zheng W, Wang QH, Liu YJ, et al. Distinct host-related dendritic cell responses during the early stage of Plasmodium yoelii infection in susceptible and resistant mice. Parasite Immunol. 2010 ; 32 (5). 324-334
86. Morita Y, Yang J, Gupta R, et al. Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis. J Clin Invest. 2001 ; 107 (10). 1275-1284
87. van Duivenvoorde LM, Han WG, Bakker AM, et al. Immunomodulatory dendritic cells inhibit Th1 responses and arthritis via different mechanisms. J Immunol. 2007 ; 179 (3). 1506-1515
88. Bluestone JA, Tang Q. How do CD4+CD25+ regulatory T cells control autoimmunity?. Curr Opin Immunol. 2005 ; 17 (6). 638-642
89. Hori S, Takahashi T, Sakaguchi S. Control of autoimmunity by naturally arising regulatory CD4+ T cells. Adv Immunol. 2003 ; 81: 331-371
90. Lu LF, Rudensky A. Molecular orchestration of differentiation and function of regulatory T cells. Genes Dev. 2009 ; 23 (11). 1270-1282
91. Liu B, Zhao H, Poon MC, et al. Abnormality of CD4(+)CD25(+) regulatory T cells in idiopathic thrombocytopenic purpura. Eur J Haematol. 2007 ; 78 (2). 139-143
92. Mahnke K, Johnson TS, Ring S, Enk AH. Tolerogenic dendritic cells and regulatory T cells: a two-way relationship. J Dermatol Sci. 2007 ; 46 (3). 159-167
93. Menges M, Rössner S, Voigtländer C, et al. Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J Exp Med. 2002 ; 195 (1). 15-21
94. Zou T, Caton AJ, Koretzky GA, Kambayashi T. Dendritic cells induce regulatory T cell proliferation through antigen-dependent and -independent interactions. J Immunol. 2010 ; 185 (5). 2790-2799
95. Sharma MD, Baban B, Chandler P, et al. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. J Clin Invest. 2007 ; 117 (9). 2570-2582
96. Verginis P, Li HS, Carayanniotis G. Tolerogenic semimature dendritic cells suppress experimental autoimmune thyroiditis by activation of thyroglobulin-specific CD4+CD25+ T cells. J Immunol. 2005 ; 174 (11). 7433-7439
97. Groux H, Fournier N, Cottrez F. Role of dendritic cells in the generation of regulatory T cells. Semin Immunol. 2004 ; 16 (2). 99-106
98. Wakkach A, Fournier N, Brun V, Breittmayer JP, Cottrez F, Groux H. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity. 2003 ; 18 (5). 605-617
99. Wang Y, Bi Y, Wu K, Wang C. Dendritic cell co-transfected with FasL and allergen genes induces T cell tolerance and decreases airway inflammation in allergen induced murine model. Mol Biol Rep. 2011 ; 38 (2). 809-817
100. Tracey D, Klareskog L, Sasso EH, Salfeld JG, Tak PP. Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther. 2008 ; 117 (2). 244-279
101. Kis-Toth K, Tsokos GC. Dendritic cell function in lupus: independent contributors or victims of aberrant immune regulation. Autoimmunity. 2010 ; 43 (2). 121-130
102. Hilkens CM, Isaacs JD, Thomson AW. Development of dendritic cell-based immunotherapy for autoimmunity. Int Rev Immunol. 2010 ; 29 (2). 156-183
103. Sidhu M, Griffiths MM, Bradley DS. Vaccination with collagen-pulsed dendritic cells prevents the onset and reduces the disease severity in the mouse model of spontaneous polychondritis. Clin Exp Immunol. 2009 ; 157 (3). 350-358
104. Pouniotis DS, Proudfoot O, Bogdanoska V, Apostolopoulos V, Fifis T, Plebanski M. Dendritic cells induce immunity and long-lasting protection against blood-stage malaria despite an in vitro parasite-induced maturation defect. Infect Immun. 2004 ; 72 (9). 5331-5339
105. Pandha HS, John RJ, Hutchinson J, et al. Dendritic cell immunotherapy for urological cancers using cryopreserved allogeneic tumour lysate-pulsed cells: a phase I/II study. BJU Int. 2004 ; 94 (3). 412-418
106. Akbar SM, Furukawa S, Hasebe A, Horiike N, Michitaka K, Onji M. Production and efficacy of a dendritic cell-based therapeutic vaccine for murine chronic hepatitis B virus carrierer. Int J Mol Med. 2004 ; 14 (2). 295-299